Hypothesis: Is age-related decline in female fertility a mitochondrial dysfunction?

  • Wednesday, January 16th, 2013

Updated on 30.10.2016.

Infertility 3

 

Hypothesis: Is age-related decline in female fertility a mitochondrial dysfunction?

Dr Sudipta Paul

The hypothesis was initially conceived and this article was originally written by Dr Sudipta Paul in 2000. The top level scientific journals rejected the hypothesis/concept at that time, perhaps it was too radical. When he was working at the IVF Unit at Centre for Life in Newcastle upon Tyne, UK he discussed the hypothesis with Professor Alison Murdoch. When asked how the hypothesis could be checked, he suggested by checking the indicators of mitochondrial function in the oocyte. As the facilities to do that were not available there it did not go any further. After 15 years results from several research studies, however, have shown the evidence that the hypothesis was correct.

The recent relevant research studies are included here before the original article.

Oocyte aging underlies female reproductive aging: biological mechanisms and therapeutic strategies

“Aged oocytes display increased chromosomal abnormality and dysfunction of cellular organelles, both of which factor into oocyte quality. In particular, mitochondrial dysfunction has been suggested as a major contributor to the reduction in oocyte quality as well as to chromosomal abnormalities in aged oocytes and embryos. Participation of oxidative stress in the oocyte aging process has been proposed because oxidative stress has the capacity to induce mitochondrial dysfunction and directly damage many intracellular components of the oocytes such as lipids, protein, and DNA. In an attempt to improve mitochondrial function in aged oocytes, several therapeutic strategies have been investigated using both animal models and assisted reproductive technology.”

Igarashi H, Takahashi T, Nagase S. Oocyte aging underlies female reproductive aging: biological mechanisms and therapeutic strategies. Reprod Med Biol (2015) 14: 159. doi:10.1007/s12522-015-0209-5.

 

Oocyte ageing and epigenetics

“In aged mouse oocytes, ATP and mitochondrial genomes are reduced to 38.4 and 44% respectively (Simsek-Duran et al. 2013). In bovine oocytes, the number of mitochondria and content of ATP are also affected by maternal age (Iwata et al. 2011).”

Zhao-Jia Ge1Heide SchattenCui-Lian Zhang1Qing-Yuan Sun. Oocyte ageing and epigenetics. Reproduction March 1, 2015 149R103-R114

 

Coenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging.

“In human, CoQ10 concentrations decrease after 30 years of age in some tissues (Morre et al., 2003; Miles et al., 2004), and perhaps this contributes to the aging process. The timing of the age-related decline in CoQ10 availability seems to coincide with the decline in fertility and the increase in embryo aneuploidies. Indeed, correlation between low plasma CoQ10 levels and spontaneous abortions were previously reported (Noia et al., 1996). In addition, levels of CoQ10 in the follicular fluid correlate with oocyte maturation and embryo grade during in vitro fertilization (Turi et al., 2012). Our results suggest that the oocyte is the beneficial target of CoQ10 supplementation. However, it is also possible that granulosa/cumulus cells and/or the uterine environment may also benefit and thus contribute to the increased reproductive capacity of CoQ10-treated females.”

Ben-Meir A et al. Coenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging. Aging Cell (2015) 14, pp887–895.

 

The aging oocyte — can mitochondrial function be improved?

Yaakov Bentov, M.D., and Robert F. Casper, M.D.
Toronto Centre for Advanced Reproductive Technology, Division of Reproductive Sciences, Department of Obstetrics andGynecology, University of Toronto, and Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario,Canada

“Our findings in the late-maternal-age oocyte mouse model have been similar (35, 36). We observed a significant decline in the expression of theenzymes involved in CoQ10 production in cumulus cellswith aging, consistent with our hypothesis that decreasedenergy production in oocytes with aging may be related to deficiency of CoQ10. In this aged animal model, we showedthat 52-week-old mice treated with CoQ10 had a significant increase in the number of ovulated eggs after stimulation, a lower mitochondrial membrane potential and mitochondrial copynumbers, andrestoredcitrate/ATP ratioincomparison with the aged controls(35, 36). The CoQ10-treated groupalso had a significantly larger litter size, a definitive positive outcome. Can the aging process in reproductive function bealtered? We believe the observations presented in this review point to the conclusion that a mechanism to increasemitochondrial function and energy production should havea positive impact on pregnancy outcome in older women. Inthis regard, supplementing the diets of older women withmitochondrial nutrients may potentially be beneficial. Mito-chondrial nutrients are naturally occurring chemicals thathave been used successfully to treat conditions associatedwith diminished mitochondrial energy production, and they appear to be very safe for both mother and fetus. Supplementation with mitochondrial nutrients such as CoQ10 andr-alpha lipoic acid (ALA) may be able to reduce the risk of trisomy and other types of chromosomal aneuploidies relatedto oocyte aging via increasing energy for chromosomal dis- junction. Studies on bovine oocytes suggest that CoQ10 could be added to culture media of the embryos for significantly im-proved mitochondrial function and ATP production(37). A strategy of supplementation of mitochondrial nutrients may lead to improvement in oocyte and embryo quality, and sub-sequently, a healthy pregnancy outcome for older women. We believe that large, properly randomized, properly controlledtrials are now needed to test the effect of mitochondrial nutrients on clinical reproductive outcomes.”

 

Germline energetics, aging and female infertility

“Direct causative relationships between impaired mitochondrial function, suboptimal bioenergetic capacity and reduced developmental competency of eggs in aging females have not yet been unequivocally established. Nevertheless, evidence for such relationships continues to solidify, as does the link between longevity pathways and fertility. Studies of hamsters and mice have reported that maternal aging is associated with significant decreases in ATP content and mitochondrial numbers in oocytes.”

Tilly JL, Sinclair DA. Germline energetics, aging and female infertility. Cell metabolism. 2013;17(6):838-850. doi:10.1016/j.cmet.2013.05.007.

 

The contribution of mitochondrial function to reproductive aging

“It is possible that mitochondrial problems can contribute to poor reproductive outcome. In addition, inheritance of dysfunctional maternal mitochondria by the next generation could increase the risk of developing adult diseases later in life. The molecular factors responsible for oocyte mitochondrial abnormalities and diminished oocyte quality remain to be elucidated. If mitochondrial abnormalities occur in oocytes of older mothers, as our review suggests, inherited mitochondrial dysfunction in the offspring may partially explain the epidemic of obesity, insulin resistance and type 2 diabetes afflicting our modern society.”

Bentov Y, Yavorska T, Esfandiari N, Jurisicova A, Casper RF. The contribution of mitochondrial function to reproductive aging. Journal of Assisted Reproduction and Genetics. 2011;28(9):773-783. doi:10.1007/s10815-011-9588-7.

 

Maternal age-related differential global expression profi les observed in human oocytes

“Mitochondrial dysfunction has been implicated in the age-related decline of oocyte competence (reviewed in Eichenlaub-Ritter et al., 2004).”

Steuerwald NM et al. Maternal age-related differential global expression profiles observed in human oocytes. RBMOnline – Vol 14. No 6. 2007 700-708 Reproductive BioMedicine Online; www.rbmonline.com/Article/2794 on web 10 April 2007 2794 on web 10 April 2007

 

 

Hypothesis: Is age-related decline in female fertility a mitochondrial dysfunction?

Dr Sudipta Paul

The hypothesis was initially conceived and this article was originally written by Dr Sudipta Paul in 2000. The top level scientific journals rejected the hypothesis/concept at that time, perhaps it was too radical. © Dr Sudipta Paul, 2000

Introduction

In humans, the fertility in female declines slowly from the age of 30 years 1, 2. Embryo implanting ability and survival start declining gradually after 30 years of age, but by more than two thirds after 40 years and in younger women with reduced ovarian reserve 3. While decline in the frequency of intercourse is one of the reasons, reduction in the quality of either the embryos arising from ageing oocytes due to higher incidence of oocyte aneuploidy or the older uterus have been implicated as the probable causes.  Controversy still exists about which one of these is the main cause or whether both of them play a role together 1, 4, 5, 6. While the suboptimal quality of the ageing oocytes and/or older uterus may be responsible for the age-related decline in female fertility, it is not clear why the functional quality of the uterus or the oocytes declines with increasing age. Recent researches have indicated the role of oxygen radical damage to the mitochondria in the somatic cells leading to mitochondrial dysfunction as the possible cause of the ageing process. In this article, a possible role of age-related mitochondrial dysfunction in the ageing oocytes and/or the uterus has been proposed to be the cause of the age-related decline in female fertility.

Older uterus or ageing oocytes

A substantial drop in the ongoing pregnancy rate per embryo transfer has been observed in women undergoing assisted reproduction (48.8% in women aged <30 years to 13.6% in women aged > 42 years). Embryo implantation rate also declines in a linear fashion, from 29% in women <34 years to approximately 5% at age 42. The reduced implantation rate in older women is apparently independent of the magnitude of their stimulation response. Though oocyte factors are held primarily responsible for the decline in fertility in older women, diminished endometrial receptivity has also been suggested as a contributor 7. It has been suggested from studies performed in women undergoing in vitro fertilisation (IVF) treatment and IVF with oocyte donation, that senescence affects both the ovary (oocytes and granulosa cells) and the uterus 1, 8. A defective vasculature of the uterus has been indicated as the possible cause of an increased miscarriage rate in women aged >40 years 1. With ovum donation, an increased rate of pregnancy loss after the completion of implantation has been observed in women >40 years. A retardation of steroid synthesis suggests that the mechanism(s) responsible for placenta formation and functioning in the uterus is affected by age 9. A negative correlation between age and fecundity has been shown in the mouse. It has been attributed to the appearance of amorphous material beneath the basal lamina of the endometrial epithelium that could impair implantation 10. Elevated levels of epidermal growth factor might also have a physiological role in fertility decline in ageing mice possibly via uterine hypertrophy 11. In cycling women >40 years, a disturbance in follicular recruitment but not in luteal function or endometrial maturation has been observed and its possible role in the decline in fertility with ageing suggested 12. Elsewhere, it has been suggested that age-related changes in the ovary account for most of the decline in fertility. Oocytes, which originate in the fetal life, decline in numbers and quality with age. The endocrine function of the ovary also declines with age leading to dysfunction of the neuroendocrine axis. The latter may be further affected by primary changes in the hypothalamus and pituitary due to ageing, although there is no such evidence in humans. The uterine vasculature may change due to the age-related endocrine dysfunction thereby losing its ability to support implantation and growth of the embryo 13. The frequency of chromosomal anomalies in abortuses increases in parallel with the age-related rise in the incidence of spontaneous miscarriages 14. That oocyte aneuploidy is one major reason for low pregnancy rates in older women, is suggested by the higher pregnancy rate in this group where young donor oocytes are used 1. Majority of the studies support this view. Degenerative changes and chromosomal abnormalities in the ageing oocyte have been implicated as the causes of the decline in female fertility with age 4, 16, 17, 18, 19, 20, 21, 22. A study, performed on women undergoing IVF, concluded that the reduction in quality of the embryos arising from ageing oocytes is the cause for age-related decline in female fertility. The blastocyst formation rate ([blastocysts/embryos on day 2] 100) and the blastocyst expansion rate ([expanded blastocysts/blastocysts] 100) according to the woman’s age on the day of I.V.F. were determined. With increase in age, the number of retrieved oocytes decreased, without alteration of the cleavage rate. In women above age 30 years, preimplantation development to blastocysts declined due to an arrest at the morula stage. Where the blastocyst stage was reached, a negative linear relationship between blastocyst expansion rate and woman’s age was found.  Increasing age led to a drastic decrease in women having at least one expanded blastocyst (<30 years, 82%; >40 years, 36%) because of reduction in gamete production and embryo development. A high delivery rate per oocyte retrieval (25.8%) was found in women above age 40 years after embryo transfer at the blastocyst stage 5. This study indicated a poor quality embryo up to the stage of blastocyst as the cause of reduction in fertility with increasing age. Although majority of the studies have suggested a decrease in the quality of the oocytes as the main cause of the age-related decline in female fertility, contribution by the uterus also remains a possibility.

Embryonic development and the mitochondria

Normal mitochondrial function in the embryo to produce adequate energy is essential for mitochondrial protein synthesis, DNA synthesis and embryonic growth 23. In a study to determine the actual and potential activities of the cytochrome system in cleavage-stage mouse embryos, three major shifts in the mode of ATP production during preimplantation stages were detected. The first, between the two-cell and late four-cell stages; the second, between the eight-cell and late morula stages; and the third, between the late morula and late blastocyst stages 2. The importance of ooplasmic factors has been postulated for the continued development of the zygote, particularly during early cleavage, when transcription of the embryonic genome is minimal 25, 26. In recent years, mitochondrial DNA (mtDNA) has been a subject of interest due to the subtle role it may have in early development 27. Sperm mitochondria, carrying potentially harmful paternal mtDNA are eliminated from the embryo at an early stage, probably by a ubiquitin-dependent mechanism 28, 29.    Therefore the mtDNA in the fetus comes from the oocyte 27, 30, 31. As a consequence, any dysfunction of the oocyte mitochondria may have profound detrimental effects on the development of the embryo.

Ageing and mitochondrial dysfunction

Mitochondrial dysfunction has been attributed as the cause of the ageing process 32, 33. Oxidative damage appears to play a critical role in causing mitochondrial dysfunction of ageing 34. The contributing factors include the intrinsic rate of proton leakage across the inner mitochondrial membrane (a correlate of oxidant formation), reduced membrane fluidity, and decreased levels and function of cardiolipin, which supports the function of many of the proteins of the inner mitochondrial membrane. Acetyl-L-carnitine, a high-energy mitochondrial substrate, appears to reverse many age-associated cellular dysfunction, partly by increasing cellular ATP production 35. With increasing age the mitochondrial function declines with an increase in the production of reactive oxygen species (ROS) and free radicals in the mitochondria. Up to a concentration range ROS may induce stress responses of the cell by altering genetic expression in order to increase energy metabolism to rescue the cell. However beyond this threshold, ROS may elicit apoptosis by induction of mitochondrial membrane permeability transition and release of cytochrome c. Recent researches have established a pivotal role of mitochondria in the early phase of apoptosis in mammalian cells 36. Observations in transgenic Drosophila melanogaster support the hypothesis that oxidative injury might directly cause the ageing process 37. The “free radical production hypothesis of aging” states that a decrease in oxygen radical production per unit of oxygen consumption near critical DNA targets (mitochondria or nucleus) increases the maximum life span of extraordinarily long-lived species like birds, primates and man 38. It has been hypothesised that oxygen free radicals may damage the mtDNA thereby inhibiting mitochondrial division leading to age-related reduction in mitochondrial numbers, a deficient energy production with decrease in protein synthesis and deterioration of physiological performance 37, 39, 40, 41. mtDNA is 20 times more susceptible to mutation than nuclear DNA 42 due to its location close to the site of reactive oxidative species production, and a lack of protective histones in mtDNA 43. Contrary to the popular belief, mitochondria can efficiently repair oxidative damage to their DNA 44.

Ageing oocyte – a mitochondrial dysfunction?

Each mitochondrion contains 2-10 copies of mtDNA in all human tissues, except oocytes and platelets, which contain only one copy per mitochondrion 42. During germ-line development in early bovine embryogenesis, the number of mitochondria increases 100-fold, from 1000 per oogonium to 100 000 per oocyte, while the number of mtDNA increases only 10-fold, from 10 000 to 100 000 45. As a result each mitochondrion contains 1 mtDNA, instead of the usual 5-10 45, 46. Only a small number of mtDNA molecules replicate and give rise to the whole cytoplasmic genotype during the late stage of oogenesis 47. This bottleneck may be a cause of the accumulation of oxidative damage to mtDNA during the ageing process 48, which also occurs in oocytes 45. Ageing of the ooplasm has been considered to be responsible for producing an abnormal meiotic spindle 17 with spindle abnormalities as the source of incorrect seggregation of chromosomes/chromatids at meiosis I 4. To overcome this problem, the possibility of using manufactured oocytes is being investigated, where the nucleus of immature oocyte from an older woman is transplanted into the cytoplast of a younger woman 49, 50. The oocytes originate in the fetal life and enter the first meiotic division that remains arrested until ovulation. In contrast to the continuous production of primary spermatocytes in the male after puberty, no primary oocytes form after birth. The first meiotic division in the primary oocytes completes just before ovulation, forming secondary oocytes 51. Therefore the age of the secondary oocytes in a woman above 40 years will be just above the woman’s age, as these were originated before her birth. This means that the oocytes would have been exposed to the ageing process for that period, during which oxidative damage to the oocyte mitochondria might lead to mitochondrial dysfunction. This may affect the functional quality of the oocyte or cause oocyte aneuploidy due to interference with the meiosis, which would have profound detrimental effect on fertilisation, protein synthesis and cell division in the fertilised ovum, migration of the fertilised ovum to the uterine cavity, implantation and subsequent development of the embryo. As normal mitochondrial function is essential for embryonic development, dysfunction of the oocyte mitochondria may be responsible for the age-related decline in female fertility. Mitochondrial dysfunction may also lead to suboptimal quality of the uterus, thereby decreasing fertility.

Conclusions

Fertility in the female declines with age. This has been attributed to the decrease in frequency of intercourse, and reduction in the quality of an older uterus or the embryos resulting from ageing oocytes. Although an older uterus may impair implantation or increase miscarriage rates due to a decreased receptivity of the endometrium or defective vasculature, majority of the studies indicated ageing oocytes as the main contributing factor. The etiology for the suboptimal function of the older uterus or ageing oocytes is not clear. Oxidative damage to mitochondria leading to mitochondrial dysfunction is considered to be the cause of age-related changes in somatic cells. The latter are associated with a decrease in protein synthesis and deterioration in physiological performance. There is evidence that age-related changes also occur in the oocyte mitochondria. The mtDNA in the embryo is inherited from the oocyte mitochondria, any dysfunction of which might have profound detrimental effect on the embryonic development. Therefore, mitochondrial dysfunction associated with increase in age might have a role in the age-related decline in female fertility.

References

1. Pellicer A, Simon C and Remohi J. Effects of aging on the female reproductive system. Hum Reprod 1995; 10 Suppl 2: 77-83.

2. Navot D, Drews MR, Bergh PA et al. Age-related decline in female fertility is not due to diminished capacity of the uterus to sustain embryo implantation. Fertil Steril 1994; 61: 97-101.

3. Hull MG, Fleming CF, Hughes AO et al. The age-related decline in female fecundity: a quantitative controlled study of implanting capacity and survival of individual embryos after in vitro fertilization. Fertil Steril 1996; 65(4): 783-790.

4. Dailey T, Dale B, Cohen J et al. Association between nondisjunction and maternal age in meiosis-II human oocytes. Am J Hum Genet 1996; 59: 176-184.

5. Janny L and Menezo YJ. Maternal age effect on early human embryonic development and blastocyst formation. Mol Reprod Dev 1996; 45(1): 31-37.

6. Marcus SF and Brinsden PR. In-vitro fertilization and embryo transfer in women aged 40 years and over. Hum Reprod Update 1996; 2(6): 459-468.

7. Rosenwaks Z, Davis OK, Damario MA. The role maternal age in assisted reproduction. Hum Reprod 1995; 10 Suppl 1: 165-173.

8. Saranti L, Allali F, Olivennes F et al. Results of oocyte donation in women with different indications, ages and therapeutic strategies. Contracept Fertil Sex 1997; 25(7-8): 643-646.

9. Cano F, Simon C, Remohi J et al. Effects of aging on the female reproductive system: evidence for a role of uterine senescence in the decline in female fecundity. Fertil Steril 1995 64(3): 584-589.

10. Shimizu K and Yamada J. Relationship of decrease in fecundity with advancing age to structural changes in mouse endometrium. J Anat 2000; 196: 111-114.

11. Tsutsumi O, Taketani Y, Oka T. Evidence for the involvement of epidermal growth factor in fertility decline in aging female mice. Horm Res 1993; 39 Suppl 1: 32-36.

12. Batista MC, Cartledge TP, Zellmer AW et al. Effects of aging on menstrual cycle hormones and endometrial maturation. Fertil Steril 1995; 64(3): 492-499.

13. Fitzgerald C, Zimon AE, Jones EE. Aging and reproductive potential in women. YaleJ Biol Med 1998; 71(5): 367-381.

14. Nasseri A and Grifo JA. Genetics, age, and infertility. Maturitas 1998; 30(2):189-192.

15. Hassold T J and Jacobs P A. Trisomy in man. Ann Rev Genet 1984; 18: 69-97.

16. Balmaceda JP, Bernardini L and Ciuffardi I. Oocyte donation in humans: a model to study the effect of age on embryo implantation rate. Hum Reprod 1994; 9(11): 2160-2163.

17 Battaglia DE, Goodwin P, Klein NA et al. Influence of maternal age on meiotic spindle assembly in oocytes from naturally cycling woman. Hum Reprod 1996; 11: 2217-2222.

18. Lim AS and Tsakok MF. Age-related decline in fertility: a link to degenerative oocytes? Fertil Steril 1997; 68(2): 265-271.

19. Navot D, Bergh PA, Williams MA et al. Poor oocyte quality rather than implantation failure as a cause of age-related decline in female fertility. Lancet 1991; 337(8754): 1375-1377.

20. Sauer MV. The impact of age on reproductive potential: lessons learnt from oocyte donation.  Maturitas 1998; 30(2): 221-225.

21. Te Velde Er, Scheffer GJ, Dorland M et al. Development and endocrine aspects of normal ovarian aging. Mol Cell Endocrinol 1998; 145(1-2): 67-73.

22. Vermeulen A. Environment, human reproduction, menopause, and andropause. Environ Health Perspect 1993; 101 Suppl 2: 91-100.

23. Oerter D and Bass R. Embryonic development and mitochondrial function. 1. Effects of chloramphenicol infusion on the synthesis of cytochrome oxidase and DNA in rat embryos during late organogenesis. Naunyn Schmiedebergs Arch Pharmacol 1975; 290 (2-3): 175-189.

24. Ginsberg I and Hillman N. Shifts in ATP synthesis during preimplantation stages of mouse embryos. J Reprod Fertil 1975; 43(1): 83-90.

25. Liu L., Day Y, Moor RM. Nuclear transfer in sheep embryos: the effect of cell-cycle coordination between nucleus and cytoplasm and the use of in vitro matured oocytes. Mol Reprod Dev 1997; 47: 255-264.

26. Van Blerkom J, Davies P, Merriam J et al. Nuclear cytoplasmic dynamics of sperm penetration, pronuclear formation and microtubule organization during fertilization and early preimplantation development in the human. Hum Reprod Update 1995; 1: 429-461.

27. Van Blerkom J. Developmental failure in human reproduction associated with preovulatory oogenesis and pre-implantation embryogenesis. In: Van Blerkom J and Molta P ed. Ultrastructure of Human Gametogenesis and Embryogenesis. Dordrecht:Kluwer 1989; 125-180.

28. Cummins JM, Kishikawa H, Mehmet D et al. Fate of genetically marked mitochondrial DNA from spermatocytes microinjected into mouse zygotes. Zygote 1999; 7(2): 151-156.

29. Sutovsky P and Schatten G. Paternal contributions to the mammalian zygote: fertilization after sperm-egg fusion. Int Rev Cytol 2000; 195: 1-65.

30. Allen JF. Separate sexes and the mitochondrial theory of ageing. J Theor Biol 1996; 180(2): 135-140.

31. Enriquez JA, Martinez-Azorin F, Garesse R et al. Human mitochondrial genetic system. Rev Neurol 1998; 26 Suppl: 21-26.

32. Maftah A, Ratinaud MH, Dumas M. Human epidermal cells progressively lose their cardiolipins during ageing without change in mitochondrial transmembrane potential. Mech Ageing Dev 1994; 77(2): 83-96.

33. Rattan SI. Cellular and molecular determinants of ageing. Indian J Exp Biol 1996; 34(1): 1-6.

34. Lenaz G, Cavazzoni M, Genova ML et al. Oxidative stress, antioxidant defences and aging. Biofactors 1998; 8(3-4): 195-204.

35. Shigenaga MK, Hagen TM, Ames BN. Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci USA 1994; 91(23): 10771-10778.

36. Lee HC and Wei YH. Mitochondrial role in life and death of the cell. J Biomed Sci 2000; 7(1): 2-15.

37. Fukagawa NK.  Aging: is oxidative stress a marker or is it causal? Proc Soc Exp Biol Med 1999; 222(3): 293-298.

38. Barja G, Cadenas S, Rojas C et al. A decrease of free radical production near critical targets as a cause of maximum longevity in animals. Comp Biochem Physiol Biochem Mol Biol 1994; 108(4): 501-512.

39. Fleming JE, Miquet J, Cottrell SF et al. Is cell aging caused by respiration-dependent injury to the mitochondrial genome? Gerontology 1982; 28(1): 44-53.

40. Feuers RJ. The effects of dietary restriction on mitochondrial dysfunction in aging. Ann N Y Acad Sci 1998; 854: 192-201.

41. Lenaz G, Bovina C, Formiggini G et al. Mitochondria, oxidative stress, and antioxidant defences. Acta Biochim Pol 1999; 46(1): 1-21.

42. Kagawa Y and Hayashi JI. Gene therapy of mitochondrial diseases using human cytoplasts. Gene Therapy 1997; 4: 6-10.

43. Tritschler HJ and Medori R. Mitochondrial DNA alteration as a source of human disorders. Neurology 1992; 43: 280-288.

44. Bohr VA and Dianor GL. Oxidative DNA damage processing in nuclear and mitochondrial DNA. Bochimie 1999; 81: 155-160.

45. Chen X, Prosser R, Simonetti S et al. Rearranged mitochondrial genomes are present in human oocytes. Am J Hum Genet 1995; 57: 239-247.

46. Robin ED and Wong R. Mitochondrial DNA molecules and virtual number of mitochondria per cell in mammalian cells. J Cell Physiol 1998;  136, 507-513.

47. Hauswirth W and Laipis P. Transmission genetics of mammalian mitochondria: a molecular model and experimental evidence. In: Quagliarello E ed. Achievements and Perspectives of Mitochondrial Research Vol 2. Amsterdam: Elsevier 1985; 49-59.

48. Cortopassi GA, Shibata D, Soong NW et al. A pattern of accumulation of somatic deletion of mitochondria DNA in aging human tissues. Proc Natl Acad Sci USA 1992; 89: 7370-7374.

49. Tsai MC, Takeuchi T, Bedford JM et al. Alternative sources of gametes: reality or science fiction? Hum Reprod 2000; 15: 988-998.

50. Zhang J, Wang CW, Krey L et al. In vitro maturation of human preovulatory oocytes reconstructed by germinal vesicle (GV) transfer. Fertil Steril 1999; 71: 726-731.

51. Jones W R. Fertilization, Implantation and Early Development of the Embryo, In: Whitfield C R ed. Dewhurst’s Textbook of Obstetrics and Gynaecology for Postgraduates. 5th edition. Oxford: Blackwell Science 1995; 64-72.

© Dr Sudipta Paul, 2000

Author

Best Examination Questions: Obstetrics & Gynaecology – The MCQ Bank

Best Examination Questions: Obstetrics & Gynaecology – The MCQ Bank No 1

Best Examination Questions: Obstetrics & Gynaecology – The MCQ Bank No 2

Best Examination Questions: Obstetrics & Gynaecology – The MCQ Bank No 3

Best Examination Questions: Obstetrics & Gynaecology – The MCQ Bank No 4 Uterine fibroids: Alternative treatment to hysterectomy or myomectomy – themedideas Facts & Figures

Best Examination Tips: Informed consent in O&G – themedideas Facts & Figures

Best Examination Tips: Cardiology Alert!!! Digoxin use linked to increased risk of Death

Best Examination Tips: Inherited Thrombophilia in O&G – themedideas Facts & Figures

Best Examination Tips: Introduction to Infertility

Best Health Tips: What are the reasons for patients’ dissatisfaction and how you could improve your level of satisfaction?

Best Health Tips: What is the most appropriate treatment option for you?

Best Health Tips: What appears the easiest treatment option may not be the best for you

Best Health Tips: What treatment appears cheap is not necessarily cost-effective

Best Health Tips: Who is a good Doctor?

Best Health Tips: What should you expect during consultation with the Doctor?

I-Y in InfertilitY (more than 80 Key points you must know) – themedideas Facts & Figures Best Unbiased Evidence Based Health Information – themedideas Facts & Figures

Best Examination Tips: “Good Medical Practice” & Medical Ethics – themedideas Facts & Figures

Best Examination Tips: Clinical Risk Management – themedideas Facts & Figures

Best Examination Tips: How to Critically Appraise a Research Publication (Paper) – themedideas Facts & Figures

Best Examination Tips: How to evaluate a Test – themedideas Facts & Figures

Best Examination Tips: Evidence Based Medicine – themedideas Facts & Figures

Best Examination Tips: Audit – themedideas Facts & Figures

Best Career Tips: Medical Interview Questions & Topics

..

 © Dr Sudipta Paul, themedideas.com, 2012

Tags: , , , ,

 



There are no comments yet, add one below.

Leave a Comment


You must be logged in to post a comment.

Gynaecology / Gynecology

Services O&G Health

Thromboembolism